Side-by-side financials for FBLG and NVS. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | FBLG | NVS |
|---|---|---|
| Market cap | - | $283.13 B |
| US-listed rank | - | #47 |
| Net income (latest FY) | -$18.65M | - |
| SEC filings | 209 | 947 |
Full pages: FibroBiologics, Inc. and Novartis AG, or browse the full rankings.